Highlights and Quick Summary
- Capex per Share for the quarter ending June 30, 2023 was -0.0 (a -Infinity% decrease compared to previous quarter)
- Year-over-year quarterly Capex per Share increased by 23.08%
- Annual Capex per Share for 2022 was -0.0 (a -43.02% decrease from previous year)
- Annual Capex per Share for 2021 was -0.01 (a -17.31% decrease from previous year)
- Annual Capex per Share for 2020 was -0.01 (a 19.54% increase from previous year)
- Twelve month Capex per Share ending June 30, 2023 was -0.0 (a -Infinity% decrease compared to previous quarter)
- Twelve month trailing Capex per Share increased by 6.67% year-over-year
Trailing Capex per Share for the last four month:
| 30 Jun '23 | 31 Mar '23 | 31 Dec '22 | 30 Sep '22 |
|---|---|---|---|
| -0.0 | 0.0 | -0.0 | -0.0 |
Visit stockrow.com/DRRX
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Capex per Share of DURECT Corporation
Most recent Capex per Shareof DRRX including historical data for past 10 years.Interactive Chart of Capex per Share of DURECT Corporation
DURECT Corporation Capex per Share for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | -0.0 | 0.0 | – | – | – |
| 2022 | -0.0 | -0.0 | -0.0 | -0.0 | -0.0 |
| 2021 | -0.0 | -0.01 | -0.0 | 0.0 | -0.01 |
| 2020 | -0.0 | -0.0 | -0.0 | -0.01 | -0.01 |
| 2019 | -0.0 | 0.0 | -0.0 | -0.0 | -0.01 |
| 2018 | -0.0 | -0.0 | -0.0 | -0.0 | -0.01 |
| 2017 | 0.0 | 0.03 | -0.0 | -0.0 | 0.03 |
| 2016 | -0.01 | -0.0 | -0.0 | -0.0 | -0.01 |
| 2015 | -0.0 | -0.01 | -0.0 | -0.0 | -0.02 |
| 2014 | -0.0 | -0.01 | -0.01 | 0.0 | -0.02 |
| 2013 | -0.0 | -0.0 | -0.0 | -0.0 | -0.01 |
| 2012 | -0.02 | -0.01 | – | – | -0.03 |
Business Profile of DURECT Corporation
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic